Osmolytes in Vaccine Production, Flocculation and Storage: a Critical Review

Overview

Journal Hum Vaccin Immunother

Specialty Allergy & Immunology

Date 2018 Oct 2

PMID 30273503

Authors

Tauheed Hasan

Kritika Kumari

Sagolsem Chandrika Devi

Jaya Handa

Tabish Rehman

Nasim Akhtar Ansari

Laishram Rajendrakumar Singh

Affiliations

Soon will be listed here.

Abstract

Small molecule osmolytes, responsible for protecting stresses have long been known to rescue proteins and enzymes from loss of function. In addition to protecting macromolecules integrity, many osmolytes also act as potential antioxidant and also help to prevent protein aggregation, amyloid formation or misfolding, and therefore are considered promising molecules for neurodegenerative and many other genetic diseases. Osmolytes are also known to be involved in the regulation of several key immunological processes. In the present review we discuss in detail the effect of these compounds on important aspects of vaccines i.e., increasing the efficiency, production and purification steps. The present review therefore will help researchers to make a better strategy in vaccine production to formulation by incorporating specific and appropriate osmolytes in the processes.

References

Yancey P . Compatible and counteracting solutes: protecting cells from the Dead Sea to the deep sea. Sci Prog. 2005; 87(Pt 1):1-24. PMC: 10367508. DOI: 10.3184/003685004783238599. View

Warepam M, Singh L . Osmolyte mixtures have different effects than individual osmolytes on protein folding and functional activity. Arch Biochem Biophys. 2015; 573:77-83. DOI: 10.1016/j.abb.2015.03.017. View

Chen D, Kristensen D . Opportunities and challenges of developing thermostable vaccines. Expert Rev Vaccines. 2009; 8(5):547-57. DOI: 10.1586/erv.09.20. View

Andreadis S, Roth C, Le Doux J, Morgan J, Yarmush M . Large-scale processing of recombinant retroviruses for gene therapy. Biotechnol Prog. 1999; 15(1):1-11. DOI: 10.1021/bp980106m. View

Ihssen J, Kowarik M, Dilettoso S, Tanner C, Wacker M, Thony-Meyer L . Production of glycoprotein vaccines in Escherichia coli. Microb Cell Fact. 2010; 9:61. PMC: 2927510. DOI: 10.1186/1475-2859-9-61. View

Leroux-Roels G . Unmet needs in modern vaccinology: adjuvants to improve the immune response. Vaccine. 2010; 28 Suppl 3:C25-36. DOI: 10.1016/j.vaccine.2010.07.021. View

Verez-Bencomo V, Fernandez-Santana V, Hardy E, Toledo M, Rodriguez M, Heynngnezz L . A synthetic conjugate polysaccharide vaccine against Haemophilus influenzae type b. Science. 2004; 305(5683):522-5. DOI: 10.1126/science.1095209. View

Paul W . Bridging innate and adaptive immunity. Cell. 2011; 147(6):1212-5. DOI: 10.1016/j.cell.2011.11.036. View

Oyaas K, Ellingsen T, Dyrset N, Levine D . Transport of osmoprotective compounds in hybridoma cells exposed to hyperosmotic stress. Cytotechnology. 2012; 17(3):143-51. DOI: 10.1007/BF00749652. View

10.

Ohtake S, Martin R, Saxena A, Lechuga-Ballesteros D, Santiago A, Barry E . Formulation and stabilization of Francisella tularensis live vaccine strain. J Pharm Sci. 2011; 100(8):3076-3087. PMC: 3356159. DOI: 10.1002/jps.22563. View

11.

Matthias D, Robertson J, Garrison M, Newland S, Nelson C . Freezing temperatures in the vaccine cold chain: a systematic literature review. Vaccine. 2007; 25(20):3980-6. DOI: 10.1016/j.vaccine.2007.02.052. View

12.

Hoffmann M, Molina-Mendiola C, Nelson A, Parks C, Reyes E, Hansen M . Co-potentiation of antigen recognition: A mechanism to boost weak T cell responses and provide immunotherapy in vivo. Sci Adv. 2015; 1(9):e1500415. PMC: 4646799. DOI: 10.1126/sciadv.1500415. View

13.

Baxter D . Active and passive immunity, vaccine types, excipients and licensing. Occup Med (Lond). 2007; 57(8):552-6. DOI: 10.1093/occmed/kqm110. View

14.

Chua F, Yap M, Oh S . Hyper-stimulation of monoclonal antibody production by high osmolarity stress in eRDF medium. J Biotechnol. 1994; 37(3):265-75. DOI: 10.1016/0168-1656(94)90133-3. View

15.

Rolfe M, Rice C, Lucchini S, Pin C, Thompson A, Cameron A . Lag phase is a distinct growth phase that prepares bacteria for exponential growth and involves transient metal accumulation. J Bacteriol. 2011; 194(3):686-701. PMC: 3264077. DOI: 10.1128/JB.06112-11. View

16.

Tuszynski M, Thal L, Pay M, Salmon D, U H, Bakay R . A phase 1 clinical trial of nerve growth factor gene therapy for Alzheimer disease. Nat Med. 2005; 11(5):551-5. DOI: 10.1038/nm1239. View

17.

Lampel A, Bram Y, Levy-Sakin M, Bacharach E, Gazit E . The effect of chemical chaperones on the assembly and stability of HIV-1 capsid protein. PLoS One. 2013; 8(4):e60867. PMC: 3618117. DOI: 10.1371/journal.pone.0060867. View

18.

Muller K, Schumacher J, Kyewski B . Half-life of antigen/major histocompatibility complex class II complexes in vivo: intra- and interorgan variations. Eur J Immunol. 1993; 23(12):3203-7. DOI: 10.1002/eji.1830231224. View

19.

Sakamoto A, Murata N . The role of glycine betaine in the protection of plants from stress: clues from transgenic plants. Plant Cell Environ. 2002; 25(2):163-171. DOI: 10.1046/j.0016-8025.2001.00790.x. View

20.

JAMES K, Bell G . Human monoclonal antibody production. Current status and future prospects. J Immunol Methods. 1987; 100(1-2):5-40. DOI: 10.1016/0022-1759(87)90170-0. View